An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia
Clinical trial NCT03424018 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03424018
- Sponsor
- BioMarin Pharmaceutical
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-12
- Primary completion
- 2031-06-01
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.